VR

Venkataramanan Ravi

Active Director Director DIN 10837754
DIN 10837754 First appointment Jun 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since Jun 2020
Shareholding value •••• Premium profile

About Venkataramanan Ravi

Data last updated:

Venkataramanan Ravi is a Director at Inventia Healthcare Limited (since 2024) and Director at Proburgeon Private Limited (since 2025). The companies operate in Pharma and Travel and Hospitality. The 2 current companies with reported revenue have a combined latest revenue of ₹622 Cr; the largest is Inventia Healthcare Limited at ₹621 Cr (FY 2025). Earlier, Venkataramanan Ravi was a Ceo(Kmp) at Aurigene Pharmaceutical Services Limited (2020–2022).

DIN 10837754
Primary Designation Director
Industry Pharma
First Appointment 08 Jun 2020
Oldest Company Age 41 yrs
Largest company Inventia Healthcare Limited · ₹621 Cr (FY 2025)
Combined revenue ₹622 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Inventia Healthcare Limited U24239MH1985PLC037597
Director15 Nov 20241985₹621 Cr (FY 2025)Active
Proburgeon Private Limited U74999PN2018PTC178443
Director11 Jan 20252018₹1.45 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ceo(Kmp)08 Jun 20202019₹645 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Inventia Healthcare Limited
Proburgeon Private Limited
Aurigene Pharmaceutical Services Limited
Premium access

Shareholding and investment profile for Venkataramanan Ravi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkataramanan Ravi

Venkataramanan Ravi currently holds 2 directorships: Inventia Healthcare Limited (Director, since 15 Nov 2024, revenue ₹621 Cr (FY 2025)); Proburgeon Private Limited (Director, since 11 Jan 2025, revenue ₹1.45 Cr (FY 2025)).

Venkataramanan Ravi was first appointed on 08 Jun 2020 as Ceo(Kmp) at Aurigene Pharmaceutical Services Limited. The most recent appointment on record is 11 Jan 2025 at Proburgeon Private Limited.

The 2 current companies of Venkataramanan Ravi that report revenue have a combined latest revenue of ₹622 Cr: Inventia Healthcare Limited ₹621 Cr (FY 2025); Proburgeon Private Limited ₹1.45 Cr (FY 2025).

Venkataramanan Ravi held 1 earlier board appointment: Aurigene Pharmaceutical Services Limited (Ceo(Kmp), 08 Jun 2020 to 25 Jan 2022).

The current boards of Venkataramanan Ravi's companies include Ajay Mangilal Luharuka (Inventia Healthcare Limited), Amit Sobti (Inventia Healthcare Limited), Ankur Janak Shah (Inventia Healthcare Limited), Ganapati Bhat Pavan (Inventia Healthcare Limited), Ganapati Bhat Pavan (Inventia Healthcare Limited), Gregory Pak Hon Wong (Inventia Healthcare Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available